Celecoxib is a COX-2 selective NSAID indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and primary dysmenorrhea. We supply it to US manufacturers of capsules.
Data from PubChem (CID 2662) and FDA’s substance registry
CAS number
169590-42-5
Molecular formula
C17H14F3N3O2S
Molecular weight
381.4g/mol
FDA UNII
IUPAC name
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
InChIKey
RZEKVGVHFLEQIL-UHFFFAOYSA-N
- Appearance
- White or almost white crystalline powder.
- Solubility
- Practically insoluble in water. Freely soluble in ethanol and soluble in methylene chloride.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Particle size drives dissolution, so state the distribution you developed with.
On the US market
- Reference product
- CelebrexNDA 020998
- Approved ANDAs
- 18 with a marketed product
- Approved forms and strengths
- Capsule 50 mg, 100 mg, 200 mg, 400 mg
- Oral suspension 10 mg/mL
- Oral solution 25 mg/mL
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com